Thirty commercially available yeast cell wall products and two reference bentonites were tested for their ability to bind aflatoxin B1 (AFB1) and zearalenone (ZON) in buffer solutions at pH 3 and pH 6.5 as well as in real gastric juice. For most products, the binding efficacy of AFB1 correlated with the ash content which was between 2.6 and 89% and constituted the inorganic non-volatile components, like mineral clays, of the samples. Samples with smectite as main ash component showed highest binding efficacy. Yet, correlation with the content of mannanooligosaccharides (MOS) and beta-glucanes from yeast cell walls was not observed. Products containing > 30% ash showed AFB1 adsorption values > 90% at least in one of the investigated media whereas most products with < 10% ash did not exceed adsorption rates of 20%. In the case of ZON, adsorption efficiency ranged between 10 and 60%. It tended to be lowest for products with MOS and beta-glucan contents <10% and greatest for products with MOS and beta-glucan contents > 50%. However, there was no general correlation between the adsorption of ZON and the concentration of MOS 
Introduction
Mycotoxins are an inherent problem in feed production and animal nutrition. In warm and moist countries, aflatoxins are among the main representatives. Aflatoxin B 1 (AFB1) is a potent carcinogen and can be metabolized in vivo to AFM1 which, in turn, can be found in milk and other animal products (Prandini et al. 2009 ). Zearalenone (ZON) is a frequently occurring mycoestrogen produced by several Fusarium species. Due to its structural similarity to estrogens like 17-β-estradiol, ZON can cause reproductive problems in mammals, e.g. (Bennett et al. 2003) .
Primary strategies to reduce the risk of mycotoxin contamination include good agricultural practices in the field (crop rotation, soil cultivation, weed and insect control, careful use of fungicides) and upon harvest as well as transportation and storage under dry and cool conditions (Jouany 2007) . However, complete avoidance of mycotoxins is not possible.
There are several approaches to cope with the problem: To lower the mycotoxin concentration in contaminated crops by physical or chemical treatment (Jouany, 2007) or to reduce the animals' mycotoxin uptake by addition of feed additives working on the basis of biological decontamination through microbes or enzymes, e.g. (Fuchs et al. 2002; Molnar et al. 2004) or on the basis of adsorption of mycotoxins to binding agents in the animals' digestive system. Binders should be non-toxic, have a high adsorption capacity (so that their inclusion level into feed may be low) and bind mycotoxins selectively and irreversibly at different pH-values and in complex systems, like the digestive tract. Several different types of binders have been tested: Bentonites like NovaSil plus (NSP, formerly called hydrated sodium calcium aluminosilicate, HSCAS, but structurally a calcium montmorillonite clay); zeolites; organoclays; charcoal; diatomaceous earth; and yeast cell wall derived products (YCP). Unlike charcoal, NSP and other bentonites have been found to selectively bind aflatoxins through chemisorption, e.g. Phillips 1995; Vekiru et al. 2007 ).
However, the adsorptive performance (adsorption capacity, selectivity etc.) of the binders can be very different even if they belong to the same mineralogical group. (regarding mineral and vitamin profile) of the feed. The mechanism of binding by β-Dglucans has been investigated by Yiannikouris and co-workers and has been discussed in several publications, e.g. (Yiannikouris et al. 2004a; Yiannikouris et al. 2006; Yiannikouris et al. 2004b; Yiannikouris et al. 2004c) . It was shown that it is important to differentiate between the adsorption affinity of whole yeast cell wall and processed cell wall. A further factor influencing the binding ability is the presence of chitin which stiffens the cell wall structure and restricts access of e.g. ZON to the binding sites of β-D-glucans (Yiannikouris et al. 2004c) . Therefore, the preparation of the cell wall material prior to its application as a mycotoxin binder is of major importance and greatly influences the adsorption ability of the final product. Hence, in order to describe the precise properties of β-D-glucan preparations, origin, molecular structure and purity are important as they are known to influence the activity of β-D-glucan preparations. It would be very useful and provide transparency for the end-user if cell wall derived products were accompanied by a certificate of analysis reporting parameters like moisture, glucan, MOS and ash content as well as other parameters like protein and fat content. The aim of this work was to test a great number of yeast cell wall based products for their ability to bind AFB1 and ZON and to correlate the respective adsorption rates with the glucomannan-and ash content in the samples. In addition, variations in binding efficiency within products of the same brand, but marketed in different countries and stemming from different lots, should be assessed.
Materials and methods

Reagents and solutions
Solid standards of AFB1 and ZON were provided by Romer Labs Diagnostic GmbH (Tulln, Austria). Acetonitrile (ACN, HPLC gradient grade) was purchased from VWR (Vienna, Austria) and trifluoroacetic acid (TFA) was obtained from Sigma-Aldrich (Vienna, Austria).
Reagents for preparation of buffer solutions were purchased from Merck (Darmstadt, Germany) and Riedel-deHaën (Seelze, Germany). Milli-Q water prepared using an ultra-pure water system (Millipore, Molsheim, France) was used in all experiments.
Stock solutions of AFB1 (85 mg/L) and ZON (100 mg/L) were prepared in ACN. The preparation of buffer solutions (citrate buffer, pH 3.0, and phosphate buffer, pH 6.5) has been described earlier (Vekiru et al. 2007 ). Real gastric juice (from swine) was cleaned from suspended particles by centrifugation and filtration.
Tested products
Thirty products containing different percentages of yeast cell wall constituents, mineral components and other ingredients were purchased worldwide. In addition, two mineral binders (products 1 and 2) were used as reference materials and for quality control purposes during our experimental work. Activated carbon and cholestyramine (Sigma-Aldrich and 
Chemisorption tests
Adsorption tests were carried out with selected products separately for AFB1 (0.2 mg/L) and ZON (0.5 mg/L) at a binder concentration of 0.5% (w/v) and at pH 6.5 (phosphate buffer) as described above. After shaking for 1 h at 37°C and centrifugation, the supernatant was removed for HPLC analysis and the pellet was re-suspended by vortexing in 1 ml of buffer.
The re-suspended pellet was washed twice with 1 mL of the buffer used for the preceding adsorption experiment and subsequently extracted 3 times with 1 mL each of methanol by shaking at 37°C (600/min) for 0.5 h. Supernatants of each washing and extraction cycle were collected and analysed separately. The chemisorption index (Cα) was calculated by dividing the difference of toxin adsorbed during the adsorption assay and of toxin desorbed in the course of the desorption steps by the total amount of toxin used for the adsorption assay. The percentage of desorption was determined by dividing the amount of toxin desorbed by the amount of toxin originally adsorbed and multiplication by 100.
Adsorption rate at increasing amounts of AFB1
A constant quantity (0.2% w/v) of selected products (which showed high AFB1 binding efficiency in the previous test) was mixed with increasing amounts of AFB1 at 37°C and the amount of toxin bound was evaluated. Adsorption tests were performed in gastric juice as described above using 0.2, 2.0, 4.0, and 8.0 mg/L AFB1 with the exception that the samples were incubated under shaking for 24 h (instead of 1 h).
HPLC-analysis
The HPLC system used consisted of an Agilent G1311A quaternary pump, a G1322A vacuum degasser, a G1313A autosampler, a G1316A column compartment and a G1315A
UV-diode array detector. AFB1 was analyzed on a Zorbax SB Aq column (150 x 4.6 mm, 5 µm particle size) equipped with a pre-column at 35°C at a flow rate of 0.7 mL/min using 50% aqueous ACN adjusted to pH 2.9 with TFA as mobile phase. The injection volume was 100 µl and the total run time was 7 min. UV-absorbance was monitored at 365 nm. Calibration was performed in the range of 10-4500 µg/L For HPLC analysis of ZON 25 µl of sample or standard solutions were injected and separated isocratically on an Eclipse XDB-C8 column (150 x 4.6 mm, 5 µm) equipped with a pre-column at 25°C and at a flow rate of 0.8 mL/min. The mobile phase consisted of 54% aqueous methanol containing 1% of acetic acid (v/v) and the UV absorbance was recorded at 275 nm. The total runtime was 8 min. Calibration was carried out in the range of 10-1000 µg/L.
Ash content
The ash content was determined based on the AOAC Official Method 942.05. In short, 5 g of sample were dried over night at 105°C and subsequently subjected to a temperature gradient with 550°C as maximum-and 105°C as final temperature prior to cooling in a dessicator. The mineral composition of the products was determined by powder X-ray diffraction (Moore et al. 1997 ). In addition, the content of carbonates was determined by Scheibler method (ÖNORM L1084) and simultaneous thermal analysis (STA, Smykatz-Kloss 1974) .
Mineral composition
Content of MOS and β-glucans
The total content of MOS and glucans was determined as described at http://www.eurasyp.org/public.technique.home.screen with minor modifications. The method involves pre-solubilization of the yeast cell wall (YCW) with concentrated sulfuric acid, subsequent acid hydrolysis, neutralization and determination of the released glucose and mannose (which are formed in proportional quantities from the glucans and mannans) by ion chromatography.
Results and discussion
Products
The ash-, MOS-and β -glucan contents and the mineral composition determined in this work are given in Table 1 Ten of the investigated products contained between 3.8 and 9.8% ash. Low percentages of ash are common in yeast cell-based products because some mineral components are necessarily added during manufacturing for anti-caking purposes. Five of the products containing < 10% ash were intended for welfare of animals by offering benefits to the GI system and by stimulating the immune system, whereas the 4 Mycosorb products were claimed to have mycotoxin binding properties. Mycotoxin binding is also the main aim of the majority of products containing 10-30% ash and 30-50% MOS and glucans. Three further products of this group were intended for well-being of animals by protecting against pathogens and by lessening the adverse effects of mycotoxins. One further product claimed to detoxify various mycotoxins by biological degradation. Finally, 7 of the 8 products (5 of the 6 yeast cell wall based products) containing more than 30% ash and less than 16% of MOS and glucans aimed at mycotoxin removal by binding and only one of these products was intended mainly to help maintain a healthy GI system.
Adsorption tests at different pH-values and in real gastric juice at pH 5
Homogenous products with small particle size can easily be tested at small scale (5 ml) for their binding efficacy by indirect pipetting technique, which includes preparation of a binder slurry and addition of slurry-aliquots to test tubes containing a certain concentration of the toxin. Using this technique, binder concentrations as low as 0.002% can be added reproducibly so that differentiation of high capacity binders (which all bind 100% of AFB1 at 0.2% of binder concentration) becomes possible. Yeast cell wall preparations, however, are not homogenous and product particles are rather coarse, so that indirect pipetting technique is not applicable. In order minimize the volume of toxin spiked solution required for the test we used 0.2% of the product (10 mg / 5 mL) for performing the adsorption tests. This resulted in 100% binding of AFB1 by the reference bentonites, but allowed differentiation of the other products.
AFB1:
The results indicated a trend that products with high ash content showed high binding efficiency of AFB1 ( Figure 1A ). For instance, all of the 8 products containing > 30% ash
showed adsorption values > 90% at least at pH 6.5. Likewise, 8 of the 10 products containing < 10% ash did not exceed adsorption values of 25% under any of the tested conditions (pH 3, pH 6.5, gastric juice). Of the 14 products containing between 10 and 30% ash, five reached adsorption efficiencies of 100%, 3 further products showed at least 50% adsorption in buffer solutions, 5 had adsorption rates between 30 and 50% and one was a very poor AFB1 binder, binding < 15%. Hence, not only the amount, but also the type of mineral constituting the ash is a key factor in adsorption of AFB1. Therefore, the mineral composition of the individual products was determined by powder X-ray diffraction. Smectite, reported as the active ingredient in additives used as aflatoxin binders (Kannewischer et al. 2006; Marroquin-Cardona et al. 2009 ), was the main ingredient in 11 and a minor component in 2 further products containing > 20% ash. With the exception of the three products of the Microbond product line (13, 14, 16) , all of these products showed > 90% AFB1 adsorption in buffer and > 70% adsorption in gastric juice. Products 3 and 4, in which smectite was not detected, showed < 50% adsorption in gastric juice. One further indication that the binding capacity of yeast cell wall derived products depends strongly on the amount and type of mineral component added is the poor binding efficacy for AFB1 of several products (e.g. products 28-32) exhibiting high MOS and β-glucan content. This observation Of the 3 media tested, highest adsorption values were obtained in phosphate buffer at pH 6.5, in most cases followed by citrate buffer at pH 3. Adsorption rates in gastric juice were lowest, possibly due to adsorption of gastric juice components to the binder, reducing the binder's capacity for AFB1 (see later for further explanations).
ZON:
In the case of ZON, most products showed adsorption rates between 20 and 40%
( Figure 1B ). Two products (No. 3, 4) were very poor binders, binding less than 15% under all of the tested conditions (pH 3, pH 6.5, gastric juice). Only 10 products showed adsorption capabilities greater than 40% in at least one of the investigated media. Interestingly, the two reference bentonites NSP and GB7 and one further product with high ash content (No. 5, 88.9% ash) were among the best adsorbents for ZON at pH 3 and 6.5 whereas 2 further products containing about 90% ash bound less than 10%. This result indicates that the type and composition of mineral binder greatly affects the product's efficiency for adsorption of ZON in buffer solutions whereas the ash content itself does not seem to be a factor.
Contrary to the results in buffer solutions, adsorption in gastric juice was low (<15%) for all products with ash contents of about 90% and MOS and β-glucan contents below 10%. This suggests that these kinds of product are hardly qualified for an in vivo application. The other 7 products showing adsorption capacities greater than 40% in at least one of the investigated media also contained considerable amounts of MOS or β-glucans, which seemed to improve the ZON adsorption rates especially in real gastric juice. Moreover, several products rich in β-glucans showed greater adsorption in gastric juice than in buffer solutions.
In our study, all products containing > 10% MOS and β-glucans showed ≥ 20% adsorption in all tested media. However, although the products with greatest MOS and β-glucan content were among those with greatest adsorption, adsorption rates did not generally increase with greater MOS and β-glucan content. The type of polysaccharide (MOS or β-glucan) was not a determinant factor, either.
Activated carbon and cholestyramine, tested as positive control samples for ZON adsorption,
showed adsorption rates of 100 and 74.5% at pH 3, of 100 and 87.6% at pH 6.5, and of 100 and 78.2% in gastric juice. Influence of the adsorption medium: Although the adsorption rate of AFB1 was different to that of ZON for each individual product, the ratio of adsorption of ZON to adsorption of AFB1 was similar at pH 3 and at pH 6 for most products. However, the ratio of adsorption of ZON to adsorption of AFB1 was greater in gastric juice than in buffer solutions for 14 products of all ash and MOS plus β-glucan contents. On the other hand, the ZON to AFB1
adsorption ratio was significantly smaller in gastric juice than in buffer solutions for the 3 products with high ash content which showed great adsorption of ZON in buffer solutions, but not in gastric juice (products 1, 2 and 5). One explanation might be that gastric juice, although subjected to filtration and centrifugation prior to use, still contains components which interfere with adsorption. For instance, adsorption of ZON to gastric juice particles occurred up to 31% in the absence of binder. Hence, adsorption rates in gastric juice were corrected by the adsorption of AFB1 and ZON, respectively, in "blank" solutions of the respective toxin prepared without binder in gastric juice. Still, adsorption rates in gastric juice
were increased compared to adsorption rates in buffer solutions for 14 products (see above).
However, gastric juice components can also adsorb to the binder and thereby reduce its capacity for binding the target mycotoxins as observed for products 1, 2 and 5 in the case of ZON. In the case of AFB1, the capacity of the reference bentonites NSP and GB7 is great enough so that this effect was not observed.
Translation of this finding into in vivo behaviour is tricky. Adsorption to gastric juice particles constitutes only a temporary mycotoxin binding as gastric juice particles are digested later in the intestinal system. Hence, the released mycotoxins should then be able to bind to mineral or MOS and -glucan components or to other indigestible diet constituents in the intestinal tract before absorption. However, due to the complexity of the involved matrices differentiation of the different adsorption processes in the GI tract is hardly possible.
Natural variation in composition and binding efficacy between different products of one brand
Frequently, products of the same brand and manufacturer, but at least in part produced in different countries are manufactured with mineral components (e.g. anti-caking agents) from local mines to avoid raw material transportation. Hence, products of the same brand but sold in different countries can differ in the type, content and composition of clay which may result in different mycotoxin adsorption efficacy. In this work, the natural variation of composition and binding efficacy of products of the same brand but of different lots and / or sold in different countries was investigated by analyzing 10 products of Mycosorb sold in 6 different (Figure 2) . The 4 products sold in Japan (JP 1-4, products 9, 10, 12, 15) contained 27.7 ± 1.6% ash with smectite as the main component, whereas the average ash content of 4 other products sold adsorption of AFB1 was significantly higher in the Japanese products where it amounted to 86.0 ± 5.2% in gastric juice, 92.3 ± 8.3% at pH 3 and 100 ± 0.0% at pH 6.5. In the other 6 investigated products (of low and medium ash content, no smectite) the adsorption of AFB1 was below 30% at pH 6.5
and even below 20% at pH 3 and in gastric juice. Similarly, the 2 products of MTB-100 sold in Vietnam and Denmark (products 21, 30) differed widely in their ash contents (5.6 and 19.2%) and in their adsorption efficacy for AFB1 (differences by a factor of 1.4 -2.2 in the individual media, see Figure 1A ), even though both contained calcite as main component. In contrast to Mycosorb and MTB-100, products of Microbond sold in the USA, South Africa and Japan (products 13, 14, 16) had similar ash contents (25.9 ± 0.9%), similar mineral composition and showed similar adsorption under different conditions (56.3 ± 1.4% at pH 3.0, 58.9 ± 13.2% at pH 6.5, 32.1 ± 2.9% in gastric juice). The same is true for the two Integral products sold in Canada (products 11, 17, relative standard deviations (RSDs) of ash content 11.7%, RSDs of adsorption under different conditions < 4.5%).
ZON:
The MOS and β-glucan contents in the 10 different products of Mycosorb varied between 32.7 and 48.6% with an average value of 41.1 ± 5.4% ( Figure 2B ). The differences in adsorption of ZON between the different products were also much lower compared to the differences in adsorption of AFB1. Adsorption rates were between 24.1 and 38.4% at pH 3, 26.6 and 38.0% at pH 6.5 and between 25.9 and 46.0% in gastric juice. The two MTBproducts (21, 30) differed both in the MOS and β-glucan content (by a factor of 1.3) and in the adsorption of ZON in different media (by a factor of 1.07, 1.25 and 1.34 in gastric juice, at pH 6.5 and at pH 3, respectively). The two Integral products from Canada (11, 17) had similar MOS and -glucan contents, but different adsorption values (between factor 1.23 in gastric juice and factor 1.39 at pH 3). On the other hand, the three Microbond products (13, 14, 16) from different countries had a relative standard deviation (RSD) of MOS and β-glucan contents of 12.2% and RSDs of adsorption in different media between 5.9 (pH 3) and 16.6% (gastric juice). 
Chemisorption tests
In Figure 3 , the chemisorption indices (Cα) of selected products are plotted together with the percentages of adsorption and desorption determined in the chemisorption experiments. In the case of AFB1, there was a strong correlation between the ash content and Cα. This is in part explained by the definition of Cα which reflects both the initial capacity of adsorption and the strength of the interactions between mycotoxin and binder. Hence, products with low adsorption under the test conditions cannot reach a Cα of 1, even if no desorption takes place. In our experiments, Cα was greatest for the mineral binders and lowest for products with low ash and high MOS and β-glucan content. In addition, product 11, despite having an ash content of 28%, showed adsorption of only 33% and thereof desorption of 75% which is in contrast to other products of medium ash content. In general, products with low adsorption had greatest desorption values and vice versa.
In the case of ZON, the increased ratio of product used for this test (0.5% w/v) resulted in significantly greater adsorption rates than the standard test using 0.2% w/v (see above). Yet, none of the tested products exceeded a chemisorption index of 0.2. This is explained by high desorption of all products (65-85% of the adsorbed amount) rather than by low adsorption values as adsorption under test conditions with 0.5% binder was between 45 and 80% for all products but one (product 3). Although products with greatest MOS and β -glucan content had greatest chemisorption indices, there was no direct correlation between Cα and the MOS plus β-glucan content. The ash content was not a factor, either. The low chemisorption indices and the high desorption values of all products indicate that ZON is adsorbed by physisorption, i.e. weak interactions with the adsorbent material and that no strong chemical bonds are formed.
Adsorption rate at increasing amount of AFB1
In this test the adsorption rate at increasing amount of the toxin was evaluated in order to compare the performance of different products which yielded similar results in the screening adsorption tests. As binder saturation during the screening test was not obtained for any of the products in the case of ZON, this test was only performed for AFB1.
On the one hand, establishment of adsorption isotherms for calculation of affinity and maximum binding capacity requires work in the range of binder saturation. On the other hand, different products should be compared under the same experimental conditions.
Hence, the same percentage of binder as used in adsorption tests was chosen (0.2% w/v) which resulted in an almost vertical line in the isotherm plot for the reference bentonite (No. Table 2 summarizes results of published in vitro studies for the commercially available products investigated in this study. Unfortunately, for most of the products it was not possible to obtain independent experimental results (provided by someone other than the manufacturer of the product) regarding in vitro binding action. It was even more difficult to find results which refer to the product as it is sold on the market and not to formulations used for research work, which do not exactly represent the content of the commercially available For instance, the amount of AFB1 bound/kg of the reference binders GB7 and NSP (products 1 and 2) was 0.32 mmol in the present work (use of 10 mg of product, 5 mL of solution containing 0.2 mg/L AFB1). The same value was obtained for several other products investigated (No. 5, 7, 8, 9, 10, 12, 15, 19) in at least one of the tested media. The difference in the adsorption capacity of the products became only visible when tests at increasing amount of AFB1 were performed (see above and Figure 4) . Comparison of our data obtained in single adsorption studies for the reference binders with literature values for
Points to consider when comparing experimental data with other published articles
Mycosorb and MTB-100 tested in single adsorption studies (Table 2) Determination of maximum adsorption capacities, which are a more useful tool for comparisons, demonstrates the superiority of mineral binders compared to yeast cell products in the adsorption of AFB1 (maximum adsorption capacities between 9 and 18 mmol AFB1/kg binder for YCP and between 260 and 420 mmol/kg binder for mineral binders, Table 2 ). This efficiency of YCP may be too low for effective binding under more complex matrix conditions (as in the intestinal tract of animals).
In the case of ZON, the best performing Mycosorb products in our investigations were able to bind 0.31 mmol ZON/kg yeast cell based product. This is in the lower range of the already reported data for single adsorption studies (see Table 2B ). Again, serious comparison with literature values was hampered by different experimental conditions. Isothermal analysis has only been reported for ZON and organoclays, not for ZON and Mycosorb. The maximum adsorption capacity of organoclays is up to 390 mmol ZON/kg binder (Lemke et al. 1998 ), a value which cannot be reached by YCP considering the low adsorption efficiencies at 0.2% of binder and 0.5 mg/L ZON in solution (see Figure 1B) .
Conclusion
This is the first study comparing the AFB1 and ZON adsorption capabilities of a great number of commercially available yeast cell products and correlating these with the ash-and MOS-as well as β -glucan contents of the products. Commercially available yeast cell based products, even of the same brand, were shown to differ in type and content of MOS and β-glucan as well as in ash content and mineral composition. Differences in the content and type of mineral clay components account for different binding capabilities of AFB1. The adsorption rate at increasing amount of the toxin (determined in order to differentiate between products with similar AFB1 binding efficiency in adsorption tests) revealed big differences between "pure" mineral binders and yeast cell based products with mineral components added.
Whereas AFB1 adsorption did not correlate with the MOS and β -glucan content of the investigated products, the ZON adsorption rate tended to increase with increasing MOS and β-glucan content. However, the adsorption capability was very low for the applied high inclusion rate of 0.2% w/v of the products and based on weak interactions. In vivo trials using mycotoxin biomarkers could be used to clarify whether the beneficial effect of yeast cell products against mycotoxicosis is based on effective binding of the toxin or on the general beneficial biological action of MOS and β-glucans to animals. In our study, ZONadsorption was independent of the type of yeast cell based product -claimed toxin binders (see Table 1 ) had similar or even lower binding capacities than yeast cell based additives designed for improvement of gastro intestinal health. Of the tested pure clay mineral products (>90% ash), some showed surprisingly great adsorption of ZON in buffer solutions (ca. 40%), but none of them adsorbed more than 15% of ZON in gastric juice.
The impact of the product composition on the adsorption properties and the influence of experimental conditions on the amount of mycotoxin bound / kg of binder stresses how important it is that manufacturers present detailed product information (moisture, β-glucan and MOS as well as ash content, and also other parameters like protein, fat and content)
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